BDBM185317 US10011588, Example 138::US10689373, Example 138::US9156829, 138

SMILES: Fc1cc(cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1)C(F)(F)F

InChI Key: InChIKey=WGMNUTPASQXMAP-ROUUACIJSA-N

Data: 6 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 185317   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Orexin receptor type 1 (Homo sapiens (Human))	BDBM185317 (US10011588, Example 138 | US10689373, Example 138 ...) Show SMILES Fc1cc(cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1)C(F)(F)F |r| Show InChI InChI=1S/C22H19F4N5O/c23-16-11-13(22(24,25)26)12-29-20(16)30-17-7-3-8-18(17)31-21(32)15-6-2-1-5-14(15)19-27-9-4-10-28-19/h1-2,4-6,9-12,17-18H,3,7-8H2,(H,29,30)(H,31,32)/t17-,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	37
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent					Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca.sup.2+ sensitive fluorescent dye. The chang...				US Patent US9156829 (2015) BindingDB Entry DOI: 10.7270/Q2X9293X
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM185317 (US10011588, Example 138 | US10689373, Example 138 ...) Show SMILES Fc1cc(cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1)C(F)(F)F |r| Show InChI InChI=1S/C22H19F4N5O/c23-16-11-13(22(24,25)26)12-29-20(16)30-17-7-3-8-18(17)31-21(32)15-6-2-1-5-14(15)19-27-9-4-10-28-19/h1-2,4-6,9-12,17-18H,3,7-8H2,(H,29,30)(H,31,32)/t17-,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	37
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent					Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca.sup.2+ sensitive fluorescent dye. The chang...				US Patent US9156829 (2015) BindingDB Entry DOI: 10.7270/Q2X9293X
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM185317 (US10011588, Example 138 | US10689373, Example 138 ...) Show SMILES Fc1cc(cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1)C(F)(F)F |r| Show InChI InChI=1S/C22H19F4N5O/c23-16-11-13(22(24,25)26)12-29-20(16)30-17-7-3-8-18(17)31-21(32)15-6-2-1-5-14(15)19-27-9-4-10-28-19/h1-2,4-6,9-12,17-18H,3,7-8H2,(H,29,30)(H,31,32)/t17-,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent					Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10689373 (2020)
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM185317 (US10011588, Example 138 | US10689373, Example 138 ...) Show SMILES Fc1cc(cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1)C(F)(F)F |r| Show InChI InChI=1S/C22H19F4N5O/c23-16-11-13(22(24,25)26)12-29-20(16)30-17-7-3-8-18(17)31-21(32)15-6-2-1-5-14(15)19-27-9-4-10-28-19/h1-2,4-6,9-12,17-18H,3,7-8H2,(H,29,30)(H,31,32)/t17-,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vertex					Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				J Med Chem 52: 6362-8 (2009) BindingDB Entry DOI: 10.7270/Q2891871
					More data for this Ligand-Target Pair
Orexin receptor type 1 (Homo sapiens (Human))	BDBM185317 (US10011588, Example 138 | US10689373, Example 138 ...) Show SMILES Fc1cc(cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1)C(F)(F)F |r| Show InChI InChI=1S/C22H19F4N5O/c23-16-11-13(22(24,25)26)12-29-20(16)30-17-7-3-8-18(17)31-21(32)15-6-2-1-5-14(15)19-27-9-4-10-28-19/h1-2,4-6,9-12,17-18H,3,7-8H2,(H,29,30)(H,31,32)/t17-,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	n/a
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent					Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				US Patent US10689373 (2020)
					More data for this Ligand-Target Pair
Orexin receptor type 1 (Homo sapiens (Human))	BDBM185317 (US10011588, Example 138 | US10689373, Example 138 ...) Show SMILES Fc1cc(cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1)C(F)(F)F |r| Show InChI InChI=1S/C22H19F4N5O/c23-16-11-13(22(24,25)26)12-29-20(16)30-17-7-3-8-18(17)31-21(32)15-6-2-1-5-14(15)19-27-9-4-10-28-19/h1-2,4-6,9-12,17-18H,3,7-8H2,(H,29,30)(H,31,32)/t17-,18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	n/a
Vertex					Assay Description Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...				J Med Chem 52: 6362-8 (2009) BindingDB Entry DOI: 10.7270/Q2891871
					More data for this Ligand-Target Pair